What is GPT-Rosalind, and what specific research tasks is it designed to support?

GPT-Rosalind is a new AI model launched by OpenAI, named after British scientist Rosalind Franklin, and designed specifically for life sciences research in areas including biochemistry, drug discovery, and translational medicine. According to the news, it is built to support evidence synthesis, hypothesis generation, experimental planning, and other multi-step research tasks—enabling researchers to accelerate the early stages of scientific discovery. It allows users to query databases, read the latest scientific papers, use other scientific tools, and suggest new experiments.

How is GPT-Rosalind being made available to researchers, and which organizations is OpenAI collaborating with to deploy it?

GPT-Rosalind is available as a research preview in ChatGPT, Codex, and via OpenAI's API for qualified customers under its trusted access deployment structure. Additionally, OpenAI is launching a free Life Sciences research plugin for Codex that connects scientists to over 50 scientific tools and data sources. The company stated it is working with customers including Amgen, Moderna, and Thermo Fisher Scientific to apply GPT-Rosalind across real-world research workflows.

OpenAI Launches AI Model GPT-Rosalind for Life Sciences Research

Apr 16, 2026

OpenAI has introduced GPT-Rosalind, an AI model designed to accelerate life sciences research including drug discovery and biochemistry. Collaborating with major firms like Amgen and Moderna, the tool aims to streamline hypothesis generation and experimental planning for pharmaceutical development.

reuters

2026-04-16

OpenAI Launches AI Model GPT-Rosalind for Life Sciences Research

OpenAI Launches AI Model GPT-Rosalind for Life Sciences Research

FAQ